A review published in JAMA found that bills introduced into the House and Senate don't go nearly as far as existing drug pricing regulations other countries. The researchers listed eight key lessons from six nations.
The FDA approved Spravato in March, but a new paper in JAMA examines some of the barriers inherent in the practice and reimbursement of psychiatry that could get in the way of widespread use of the drug.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Greater transparency about conflicts of interest could curb punitive actions like MSKCC executive's resignation last month, study author says.
Amid the drug pricing debate, the findings show that trials can be run at relatively low cost and still generate high-quality data, the study's lead author said.
The man Donald Trump has picked to be HHS secretary has vocally opposed the new Medicare payment program and is likely to revoke it.
In a study published Tuesday in JAMA, Anthem subsidiary CareMore Health Plan demonstrated how it collaborated with the ride service Lyft to reduce patient waiting times by 30 percent and cut per-ride costs by 32.4 percent.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Policymakers must find a way to tighten rules and strengthen oversight surrounding patent protections and exclusivity without chilling innovation. the study said.
In a study published in JAMA, researchers at UCSF used an innovative protein measurement assay developed by healthcare technology company SomaLogic to detect 1,130 different proteins in the plasma of nearly 2,000 individuals already diagnosed with coronary heart disease.
Despite the fact that women do as much medical research as their male counterparts.
The staid Journal of the American Medical Association is getting into the field of healthcare innovation. JAMA won't be bankrolling startups or conducting medical research, but rather will spend 2016 highlighting innovations specifically in healthcare delivery.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
A research letter about healthcare data breaches, published in the Journal of the American Medical Association in April, contained numerous errors, the authors and the publication admitted, though none apparently affected the study's conclusions.
The United States shouldn’t worry just yet about losing the number one spot as far as disease-related research in the world goes – that’s pretty solid – but that doesn’t mean the country is steadily moving forward the way it could or should. A study published online in the American Medical Association’s journal JAMA demonstrates […]
It has been debatable recently how beneficial mammograms really are, considering reports of so many false positives that can lead to biopsies and anxiety. But it looks like this procedure is still the best bet we have in detecting breast cancer and saving lives. To make it easier to grasp the big picture, Dr. Jill Jin, […]